相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Incidence of teicoplanin adverse drug reactions among patients with vancomycin-associated adverse drug reactions and its risk factors
Byung-Keun Kim et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2020)
Teicoplanin biosynthesis: unraveling the interplay of structural, regulatory, and resistance genes
Oleksandr Yushchuk et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2020)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Effective Chemicals against Novel Coronavirus (COVID-19) in China
Wei Liu et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
Chloroquine for the 2019 novel coronavirus SARS-CoV-2
Philippe Colson et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Guangdi Li et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Ivermectin and COVID-19: Keeping Rigor in Times of Urgency
Carlos Chaccour et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)
COVID-19 in Latin America: The implications of the first confirmed case in Brazil
Alfonso J. Rodriguez-Morales et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
Markus Hoffmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Response to the editorial COVID-19 in patients with cardiovascular diseases. Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes
Christian Funck-Brentano et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2020)
Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More
Abinit Saha et al.
ARCHIVES OF MEDICAL RESEARCH (2020)
Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis
Omer Gendelman et al.
AUTOIMMUNITY REVIEWS (2020)
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection
David N. Juurlink
CANADIAN MEDICAL ASSOCIATION JOURNAL (2020)
Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19
Annsea Park et al.
CELL HOST & MICROBE (2020)
Design and Synthesis of 2-(1-Alkylaminoalkyl)pyrazolo[1,5-a]pyrimidines as New Respiratory Syncytial Virus Fusion Protein Inhibitors
Toru Yamaguchi-Sasaki et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19
Virginia D. Schmith et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19
Bharat Damle et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Colchicine may not be effective in COVID-19 infection; it may even be harmful?
Medine Cumhur Cure et al.
CLINICAL RHEUMATOLOGY (2020)
The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design
Spyridon G. Deftereos et al.
HELLENIC JOURNAL OF CARDIOLOGY (2020)
Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin
Hartmut Derendorf
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
Christian A. Devaux et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Teicoplanin: an alternative drug for the treatment of COVID-19?
Sophie Alexandra Baron et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
A Review of SARS-CoV-2 and the Ongoing Clinical Trials
Yung-Fang Tu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
COVID-19 and emerging viral infections: The case for interferon lambda
Ludmila Prokunina-Olsson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Treatment options for COVID-19: The reality and challenges
Shio-Shin Jean et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Jianjun Gao et al.
BIOSCIENCE TRENDS (2020)
TMPRSS2 and COVID-19: serendipity or Opportunity for Intervention?
Konrad H. Stopsack et al.
CANCER DISCOVERY (2020)
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Ivan Fan-Ngai Hung et al.
LANCET (2020)
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
Nicholas J. Mercuro et al.
JAMA CARDIOLOGY (2020)
Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit
Francis Bessiere et al.
JAMA CARDIOLOGY (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur
Zhenming Jin et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
Ka-Tim Choy et al.
ANTIVIRAL RESEARCH (2020)
Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
Georgia Ragia et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2020)
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
Carlo Perricone et al.
JOURNAL OF AUTOIMMUNITY (2020)
Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?
Angela Patri et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect
Julien Andreani et al.
MICROBIAL PATHOGENESIS (2020)
Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial
Seyed Sina Naghibi Irvani et al.
TRIALS (2020)
Hydroxychloroquine versus Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS) Protocol for a Pragmatic, Open-Label, Active Comparator Trial
Samuel M. Brown et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2020)
Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance
R. Choudhary et al.
NEW MICROBES AND NEW INFECTIONS (2020)
Cytokine storm and colchicine potential role in fighting SARS-CoV-2 pneumonia
Antonio Vitiello et al.
ITALIAN JOURNAL OF MEDICINE (2020)
Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model
Bo Ram Beck et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses
Liang Shen et al.
JOURNAL OF VIROLOGY (2019)
Identification of a Novel Enhancer/Chromatin Opening Element Associated with High-Level γ-Globin Gene Expression (vol 38, e00197-18, 2018)
Yong Shen et al.
MOLECULAR AND CELLULAR BIOLOGY (2019)
Advances in respiratory virus therapeutics - A meeting report from the 6th for isirv Antiviral Group conference
John H. Beigel et al.
ANTIVIRAL RESEARCH (2019)
Inhibitors of nuclear transport
David A. Jans et al.
CURRENT OPINION IN CELL BIOLOGY (2019)
A New Use for an Old Drug: Carmofur Attenuates Lipopolysaccharide (LPS)-Induced Acute Lung Injury via Inhibition of FAAH and NAAA Activities
Kangni Wu et al.
FRONTIERS IN PHARMACOLOGY (2019)
Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase
Ariane J. Brown et al.
ANTIVIRAL RESEARCH (2019)
Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine
Petter Andersen et al.
VIRUSES-BASEL (2019)
Efficacy and Tolerability of Lopinavir/Ritonavir- and Efavirenz-Based Initial Antiretroviral Therapy in HIV-1-Infected Patients in a Tertiary Care Hospital in Beijing, China
Bin Su et al.
FRONTIERS IN PHARMACOLOGY (2019)
Favipiravir as a potential countermeasure against neglected and emerging RNA viruses
Leen Delang et al.
ANTIVIRAL RESEARCH (2018)
Old and new glycopeptide antibiotics: From product to gene and back in the post-genomic era
Giorgia Letizia Marcone et al.
BIOTECHNOLOGY ADVANCES (2018)
Colchicine: an ancient drug with novel applications
B. Dasgeb et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Maria L. Agostini et al.
MBIO (2018)
The Natural Compound Homoharringtonine Presents Broad Antiviral Activity In Vitro and In Vivo
Hui-Jun Dong et al.
VIRUSES-BASEL (2018)
Reflections on the number of independent solutions for forest spatial harvest scheduling problems: a case of simulated annealing
L. Dong et al.
SILVA FENNICA (2018)
Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo(2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses
Dustin Siegel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
Yousuke Furuta et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2017)
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Emetine inhibits replication of RNA and DNA viruses without generating drug-resistant virus variants
Nitin Khandelwal et al.
ANTIVIRAL RESEARCH (2017)
Core regulatory components of the PHO pathway are conserved in the methylotrophic yeast Hansenula polymorpha
Ying Zhou et al.
CURRENT GENETICS (2016)
Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
Nan Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Late Ebola virus relapse causing meningoencephalitis: a case report
Michael Jacobs et al.
LANCET (2016)
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Travis K. Warren et al.
NATURE (2016)
Coronaviruses - drug discovery and therapeutic options
Alimuddin Zumla et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
From Erythromycin to Azithromycin and New Potential Ribosome-Binding Antimicrobials
Dubravko Jelic et al.
ANTIBIOTICS-BASEL (2016)
Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
Jasper Fuk-Woo Chan et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Colchicine-Update on mechanisms of action and therapeutic uses
Ying Ying Leung et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Nucleocytoplasmic transport of nucleocapsid proteins of enveloped RNA viruses
Wahyu N. Wulan et al.
FRONTIERS IN MICROBIOLOGY (2015)
Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
Adriaan H. de Wilde et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Arbidol as a broad-spectrum antiviral: An update
Julie Blaising et al.
ANTIVIRAL RESEARCH (2014)
Glycopeptide antibiotics: Back to the future
Mark S. Butler et al.
JOURNAL OF ANTIBIOTICS (2014)
Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin
M. Y. F. Tay et al.
ANTIVIRAL RESEARCH (2013)
Pharmacokinetic study of omacetaxine mepesuccinate administered subcutaneously to patients with advanced solid and hematologic tumors
John Nemunaitis et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome
Takuma Misawa et al.
NATURE IMMUNOLOGY (2013)
Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques
Darryl Falzarano et al.
NATURE MEDICINE (2013)
Colchicine and its various physicochemical and biological aspects
Sameer Sapra et al.
MEDICINAL CHEMISTRY RESEARCH (2013)
Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity
Natalia Realini et al.
SCIENTIFIC REPORTS (2013)
Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug
Eloise Mastrangelo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
An AlphaScreen®-Based Assay for High-Throughput Screening for Specific Inhibitors of Nuclear Import
Kylie M. Wagstaff et al.
JOURNAL OF BIOMOLECULAR SCREENING (2011)
Atazanavir A Review of its Use in the Management of HIV-1 Infection
Katherine F. Croom et al.
DRUGS (2009)
Preventing Ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3
Joonil Jung et al.
HUMAN MOLECULAR GENETICS (2009)
Arbidol: A broad-spectrum antiviral compound that blocks viral fusion
Y. S. Boriskin et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Atazanavir/ritonavir: A review of its use in HIV therapy
Nils von Hentig
DRUGS OF TODAY (2008)
Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century
Jean-Marc Rolain et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes
Neal D. Barnard et al.
DIABETES CARE (2006)
New insights into the antiviral effects of chloroquine
A Savarino et al.
LANCET INFECTIOUS DISEASES (2006)
Origin, structure, and activity in vitro and in vivo of dalbavancin
A Malabarba et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J. Vincent et al.
VIROLOGY JOURNAL (2005)
Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs
ELC Tan et al.
EMERGING INFECTIOUS DISEASES (2004)
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
CM Chu et al.
THORAX (2004)
分享论文
